{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:04:58Z","timestamp":1784358298125,"version":"3.55.0"},"reference-count":24,"publisher":"Japanese Association of Rehabilitation Medicine","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PRM"],"published-print":{"date-parts":[[2021]]},"DOI":"10.2490\/prm.20210012","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T22:13:02Z","timestamp":1613772782000},"page":"n\/a","source":"Crossref","is-referenced-by-count":10,"title":["Effects of Lee Silverman Voice Treatment (LSVT LOUD) on Swallowing in Patients with Progressive Supranuclear Palsy: A Pilot Study"],"prefix":"10.2490","volume":"6","author":[{"given":"Sonoko","family":"Nozaki","sequence":"first","affiliation":[{"name":"Wakakusa Tatsuma Rehabilitation Hospital, Daito, Japan"},{"name":"Kansai Rosai Hospital, Amagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Fujiu-kurachi","sequence":"additional","affiliation":[{"name":"International University of Health and Welfare, Narita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Tanimura","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital, Amagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiyo","family":"Ishizuka","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital, Amagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Miyata","sequence":"additional","affiliation":[{"name":"Kansai Medical University Hospital, Hirakata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Sugishita","sequence":"additional","affiliation":[{"name":"Takasago Municipal Hospital, Takasago, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Imai","sequence":"additional","affiliation":[{"name":"Ashiya Municipal Hospital, Ashiya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Nishiguchi","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital, Amagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Furuta","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital, Amagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Yorifuji","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital, Amagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1338","reference":[{"key":"1","unstructured":"1. Japan Intractable Disease Information Center: 2020. [in Japanese] https:\/\/www.nanbyou.or.jp\/entry\/4115 Accessed 7 Nov 2020"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop. Neurology 1996;47:1\u20139. PMID:8710059, DOI:10.1212\/WNL.47.1.1","DOI":"10.1212\/WNL.47.1.1"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, M\u00fcller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I, Movement Disorder Society-endorsed PSP Study Group: Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria. Mov Disord 2017;32:853\u2013864. PMID:28467028, DOI:10.1002\/mds.26987","DOI":"10.1002\/mds.26987"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. O\u2019Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, Revesz T, Lees AJ: Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 2008;131:1362\u20131372. PMID:18385183, DOI:10.1093\/brain\/awn065","DOI":"10.1093\/brain\/awn065"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5.Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJ: Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 2003; 25; 60(6):910\u2013916. .DOI:10.1212\/01.wnl.0000052991.70149.68","DOI":"10.1212\/01.WNL.0000052991.70149.68"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Glasmacher SA, Leigh PN, Saha RA: Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2017;88:402\u2013411. PMID:28250027, DOI:10.1136\/jnnp-2016-314956","DOI":"10.1136\/jnnp-2016-314956"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. dell\u2019Aquila C, Zoccolella S, Cardinali V, de Mari M, Iliceto G, Tartaglione B, Lamberti P, Logroscino G: Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients. Parkinsonism Relat Disord 2013;19:980\u2013985. PMID:23968651, DOI:10.1016\/j.parkreldis.2013.06.014","DOI":"10.1016\/j.parkreldis.2013.06.014"},{"key":"8","unstructured":"8. Sulena GD, Gupta D, Sharma AK, Singh B: Clinical profile of dysphagia in patients with Parkinson\u2019s disease, progressive supranuclear palsy and multiple system atrophy. J Assoc Physicians India 2017;65:32\u201337."},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Johnston BT, Castell JA, Stumacher S, Colcher A, Gideon RM, Li Q, Castell DO: Comparison of swallowing function in Parkinson\u2019s disease and progressive supranuclear palsy. Mov Disord 1997;12:322\u2013327. PMID:9159726, DOI:10.1002\/mds.870120310","DOI":"10.1002\/mds.870120310"},{"key":"10","unstructured":"10. Sale P, Castiglioni D, De Pandis MF, Torti M, Dall\u2019armi V, Radicati FG, Stocchi F: The Lee Silverman Voice Treatment (LSVT\u00ae) speech therapy in progressive supranuclear palsy. Eur J Phys Rehabil Med 2015;51:569\u2013574."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11.Goetz CG, Leurgans S, Lang AE, Litvan I: Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. Neurology 2003;60(6):917\u2013922.","DOI":"10.1212\/01.WNL.0000052686.97625.27"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Ramig LO, Countryman S, O\u2019Brien C, Hoehn M, Thompson L: Intensive speech treatment for patients with Parkinson\u2019s disease: short- and long-term comparison of two techniques. Neurology 1996;47:1496\u20131504. PMID:8960734, DOI:10.1212\/WNL.47.6.1496","DOI":"10.1212\/WNL.47.6.1496"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ramig LO, Sapir S, Fox C, Countryman S: Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson\u2019s disease: a comparison with untreated patients and normal age-matched controls. Mov Disord 2001;16:79\u201383.","DOI":"10.1002\/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Ramig LA, Fox C: The integral role of speech production in the science and treatment of Parkinson\u2019s disease. Mov Disord 2012;27:811\u2013813. PMID:22674515, DOI:10.1002\/mds.25046","DOI":"10.1002\/mds.25046"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Ramig LO, Sapir S, Countryman S, Pawlas AA, O\u2019Brien C, Hoehn M, Thompson LL: Intensive voice treatment (LSVT) for patients with Parkinson\u2019s disease: a 2 year follow up. J Neurol Neurosurg Psychiatry 2001;71:493\u2013498. PMID:11561033, DOI:10.1136\/jnnp.71.4.493","DOI":"10.1136\/jnnp.71.4.493"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Sharkawi AE, Ramig L, Logemann JA, Pauloski BR, Rademaker AW, Smith CH, Pawlas A, Baum S, Werner C: Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study. J Neurol Neurosurg Psychiatry 2002;72:31\u201336. PMID:11784821, DOI:10.1136\/jnnp.72.1.31","DOI":"10.1136\/jnnp.72.1.31"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Miles A, Jardine M, Johnston F, de Lisle M, Friary P, Allen J: Effect of Lee Silverman Voice Treatment (LSVT LOUD\u00ae) on swallowing and cough in Parkinson\u2019s disease: a pilot study. J Neurol Sci 2017;383:180\u2013187. PMID:29246611, DOI:10.1016\/j.jns.2017.11.015","DOI":"10.1016\/j.jns.2017.11.015"},{"key":"18","unstructured":"18. The fourth version of VF standard procedure (detailed version) [in Japanese] Japanese Dysphagia Rehabil 2014;18(2):166\u2013186. https:\/\/www.jsdr.or.jp\/wp-content\/uploads\/file\/doc\/VF18-2-p166-186.pdf"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Lof GL, Robbins J: Test-retest variability in normal swallowing. Dysphagia 1990;4:236\u2013242. PMID:2209099, DOI:10.1007\/BF02407271","DOI":"10.1007\/BF02407271"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Itoh M, Furukawa M: Speech intelligibility of glossectomized patients with reconstruction using myocutaneous flap. Jpn J Logop Phoniatr 1991;32:347\u2013353. DOI:10.5112\/jjlp.32.347","DOI":"10.5112\/jjlp.32.347"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Narayana S, Fox PT, Zhang W, Franklin C, Robin DA, Vogel D, Ramig LO: Neural correlates of efficacy of voice therapy in Parkinson\u2019s disease identified by performance-correlation analysis. Hum Brain Mapp 2010;31:222\u2013236. PMID:19639554, DOI:10.1002\/hbm.20859","DOI":"10.1002\/hbm.20859"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Hamdy S, Rothwell JC, Brooks DJ, Bailey D, Aziz Q, Thompson DG: Identification of the cerebral loci processing human swallowing with H2(15)O PET activation. J Neurophysiol 1999;81:1917\u20131926. PMID:10200226, DOI:10.1152\/jn.1999.81.4.1917","DOI":"10.1152\/jn.1999.81.4.1917"},{"key":"23","unstructured":"23. Nozaki S, Matsui T, Umaki Y, Yoshikawa H, Kaneto T, Sugishita S, Imai T, Fukuoka T, Oguro D, Inokawa M, Domen K, Daimon T: Rhythm therapy with a metronome to treat dysphagia in patients with Parkinson\u2019s disease. Deglutition 2012;1:400\u2013412."},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Pitts T, Bolser D, Rosenbek J, Troche M, Okun MS, Sapienza C: Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease. Chest 2009;135:1301\u20131308. PMID:19029430, DOI:10.1378\/chest.08-1389","DOI":"10.1378\/chest.08-1389"}],"container-title":["Progress in Rehabilitation Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/prm\/6\/0\/6_20210012\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T03:57:15Z","timestamp":1613793435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/prm\/6\/0\/6_20210012\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":24,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2490\/prm.20210012","relation":{},"ISSN":["2432-1354"],"issn-type":[{"value":"2432-1354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}